tiprankstipranks
AbbVie (ABBV)
NYSE:ABBV

AbbVie (ABBV) Technical Analysis

20,393 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
6Neutral
3Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
AbbVie’s (ABBV) Moving Averages Convergence Divergence (MACD) indicator is 1.34, suggesting AbbVie is a Sell.
AbbVie’s (ABBV) 20-Day exponential moving average is 164.65, while AbbVie’s (ABBV) share price is $168.59, making it a Buy.
AbbVie’s (ABBV) 50-Day exponential moving average is 164.84, while AbbVie’s (ABBV) share price is $168.59, making it a Buy.

AbbVie (ABBV) Pivot Points

Jun 16, 2024, 11:01 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
163.51
164.25
165.41
166.15
167.31
168.05
169.21
Fibonacci
164.25
164.98
165.43
166.15
166.88
167.33
168.05
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

AbbVie (ABBV) Moving Averages

Jun 16, 2024, 11:01 AM
Period
Simple
Exponential
MA5
167.88Buy
167.44Buy
MA10
166.52Buy
166.19Buy
MA20
163.08Buy
164.65Buy
MA50
163.65Buy
164.84Buy
MA100
168.78Sell
164.04Buy
MA200
157.56Buy
156.11Buy
AbbVie’s (ABBV) 10-Day exponential moving average is 166.19, while AbbVie’s (ABBV) share price is $168.59, making it a Buy.
AbbVie’s (ABBV) 100-Day exponential moving average is 164.04, while AbbVie’s (ABBV) share price is $168.59, making it a Buy.
AbbVie’s (ABBV) stock price is $168.59 and AbbVie’s (ABBV) 50-day simple moving average is 163.65, creating a Buy signal.
AbbVie’s (ABBV) stock price is $168.59 and AbbVie’s (ABBV) 100-day simple moving average is 168.78, creating a Sell signal.
AbbVie’s (ABBV) stock price is $168.59 and AbbVie’s (ABBV) 200-day simple moving average is 157.56, creating a Buy signal.

AbbVie (ABBV) Technical Indicators

Jun 16, 2024, 11:01 AM
Name
Value
Implied Action
RSI (14)
59.21
Neutral
STOCH (9,6)
71.05
Neutral
STOCHRSI (14)
78.63
Neutral
MACD (12,26)
1.34
Sell
ADX (14)
23.06
Neutral
Williams %R
-12.58
Sell
CCI (14)
79.05
Neutral
ATR (14)
3.16
-
Ultimate Oscillator
63.48
Neutral
ROC
7.34
Buy
AbbVie’s (ABBV) Relative Strength Index (RSI) is 59.21, creating a Neutral signal.
AbbVie’s (ABBV) Trend Strength Indicator (ADX) is 23.06, creating a Neutral signal.
AbbVie’s (ABBV) Commodity Channel Index (CCI) is 79.05, creating a Neutral signal.
AbbVie’s (ABBV) Price Rate of Change (ROC) is 7.34, creating a Buy signal.

FAQ

Is ABBV a Buy, Hold, or Sell?
Based on ABBV’s technical indicators, ABBV is a Buy.
    What is ABBV’s RSI (14)?
    ABBV’s RSI (14) is 59.21, which suggests ABBV is a Neutral.
      What is ABBV’s MACD?
      ABBV’s MACD is 1.34, which suggests ABBV is a Sell.
        What is ABBV’s 5-day moving average?
        ABBV’s 5-day moving average is 167.88, which suggests ABBV is a Buy.
          What is ABBV’s 20-day moving average?
          ABBV 20-day moving average is 163.08, which suggests ABBV is a Buy.
            What is ABBV’s 50-day moving average?
            ABBV’s 50-day moving average is 163.65, which suggests ABBV is a Buy.
              What is ABBV’s 200-day moving average?
              ABBV’s 200-day moving average is 157.56, which suggests ABBV is a Buy.
                What is ABBV’s Williams % R (14)?
                ABBV’s Williams % R (14) is -12.58, which suggests ABBV is a Sell.
                  What is ABBV’s CCI (14)?
                  ABBV’s CCI (14) is 79.05, which suggests ABBV is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis